|
|
 |
|
Viewing report
|
|
|
|
US OTC Pharmaceutical Market Trends & Potential
Pharma-Reports, Oct 2011, Pages: 78
OTC pharmaceuticals, or over-the-counter medicines, are pharmaceutical drugs that are sold directly to a consumer without a prescription from a doctor. This is different from prescription drugs because they will not be sold to customers without a doctor's prescription.
This research report provides an analysis of the U.S. OTC Pharmaceutical industry. It provides and analysis of this high-growth industry in terms of market value, market segmentation, competitive landscape and the major players.
The United States has a large market for OTC pharmaceuticals, and it is regulated by the Food and Drug Administration (FDA). While the laws governing OTC pharmaceuticals are very strict, the market itself has grown over the years and has many major players operating in the industry.
With market growth mitigating rivalry in the market, manufacturers are focusing on product differentiation in order to make a niche for themselves.
With the global OTC pharmaceuticals industry expected to grow at a moderate pace in the coming years, the U.S. OTC pharmaceuticals market is also looking for a decelerated growth till the year 2014. The industry is expected to have a market value of $31.9 billion by the end of 2014.
Major pharmaceutical companies are profiled including Bristol Myers Squibb, Novartis, Bayer, GlaxoSmithKline, and many others, major product and services they offer, and a SWOT Analysis for the leading companies. The U.S. OTC Drug Monograph is also analyzed in-depth in this research report.
This report is a comprehensive profile of the U.S. OTC Pharmaceutical Industry.
|
|
|
|
